Clinical Trial Update: Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination chemotherapy regimen as first-line treatment for advanced or metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Oklahoma | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED